{"id":4303,"date":"2026-07-13T15:51:40","date_gmt":"2026-07-13T13:51:40","guid":{"rendered":"https:\/\/cerenef.org\/?p=4303"},"modified":"2026-07-13T16:16:49","modified_gmt":"2026-07-13T14:16:49","slug":"actualites","status":"publish","type":"post","link":"https:\/\/cerenef.org\/en\/actualites\/","title":{"rendered":"News"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"4303\" class=\"elementor elementor-4303\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-909c521 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"909c521\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-c1eff47\" data-id=\"c1eff47\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3eca7ab elementor-widget elementor-widget-html\" data-id=\"3eca7ab\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div style=\"font-family:Arial,sans-serif;max-width:960px;margin:0 auto;padding:48px 20px 64px;\">\n\n  <!-- HEADER -->\n  <div style=\"margin-bottom:40px;\">\n    <span style=\"font-size:11px;font-weight:700;letter-spacing:.2em;text-transform:uppercase;color:#cd696b !important;\">Referral centre<\/span>\n    <h2 style=\"font-size:28px;font-weight:700;color:#212e53 !important;margin:8px 0 0;line-height:1.2;\">Neurofibromatosis News<\/h2>\n    <div style=\"width:48px;height:3px;background:#4a909d;margin-top:14px;\"><\/div>\n  <\/div>\n\n  <!-- CARTE 01 - pleine largeur, fond navy -->\n  <div style=\"background:#212e53;border-radius:10px;padding:32px 36px;margin-bottom:20px;display:flex;justify-content:space-between;align-items:flex-start;gap:24px;\">\n    <div style=\"flex:1;\">\n      <span style=\"display:inline-block;font-size:10px;font-weight:700;letter-spacing:.15em;text-transform:uppercase;background:#4a909d;color:#fff !important;padding:4px 12px;border-radius:4px;margin-bottom:16px;\">European Network<\/span>\n      <h3 style=\"font-size:18px;font-weight:700;color:#fff !important;margin:0 0 12px;line-height:1.4;\">**A New European Momentum with the COST Action INTERACT-NF (CA25150)**<\/h3>\n      <p style=\"font-size:14px;line-height:1.75;color:rgba(255,255,255,.75) !important;margin:0;\">**Our application to the COST Action INTERACT-NF (CA25150) has been successfully accepted. This European network aims to strengthen collaboration among clinicians, basic and translational researchers, people living with neurofibromatoses and their families, as well as industrial and institutional partners, in order to accelerate progress in the field of neurofibromatoses.**<\/p>\n    <\/div>\n    <div style=\"font-size:72px;font-weight:700;color:rgba(255,255,255,.08) !important;line-height:1;flex-shrink:0;align-self:flex-end;\">01<\/div>\n  <\/div>\n\n  <!-- LIGNE 2 : cartes 02 et 03 c\u00f4te \u00e0 c\u00f4te -->\n  <div style=\"display:grid;grid-template-columns:1fr 1fr;gap:20px;margin-bottom:20px;\">\n\n    <!-- CARTE 02 -->\n    <div style=\"background:#fff;border-radius:10px;padding:28px 28px 24px;border-top:4px solid #4a909d;box-shadow:0 1px 6px rgba(0,0,0,.07);display:flex;flex-direction:column;gap:12px;\">\n      <div style=\"display:flex;align-items:center;gap:10px;flex-wrap:wrap;\">\n        <span style=\"font-size:10px;font-weight:700;letter-spacing:.12em;text-transform:uppercase;background:#e8f2ea;color:#3d7a4e !important;padding:3px 10px;border-radius:4px;\">International Congress<\/span>\n        <span style=\"font-size:12px;color:#888 !important;\">Denver - 2026<\/span>\n      <\/div>\n      <h3 style=\"font-size:16px;font-weight:700;color:#212e53 !important;margin:0;line-height:1.4;\">Highlights from the CTF International Neurofibromatosis Conference in Denver<\/h3>\n      <p style=\"font-size:13.5px;line-height:1.7;color:#555 !important;margin:0;\">Our team participated in the latest Children's Tumor Foundation (CTF) International Neurofibromatosis Conference in Denver, where we presented several research projects:<\/p>\n      <ul style=\"margin:0;padding-left:18px;display:flex;flex-direction:column;gap:6px;\">\n        <li style=\"font-size:13px;line-height:1.6;color:#555 !important;\">Clinical research, focusing in particular on mosaic forms of NF1, NF1-associated vascular manifestations, and updated life expectancy data.<\/li>\n        <li style=\"font-size:13px;line-height:1.6;color:#555 !important;\">Preclinical research, evaluating novel therapeutic strategies targeting cutaneous neurofibromas in NF1 mouse models.<\/li>\n        <li style=\"font-size:13px;line-height:1.6;color:#555 !important;\">Collaborative research, highlighting the progress of the international REiNS working group in developing standardized assessment tools for cutaneous neurofibromas.<\/li>\n      <\/ul>\n      <div style=\"margin-top:8px;\">\n        <a href=\"https:\/\/www.ctf.org\/wp-content\/uploads\/2026\/06\/2026-NF-Conference-Abstract-Book.pdf\" target=\"_blank\" rel=\"noopener\" style=\"display:inline-flex;align-items:center;gap:6px;font-size:13px;font-weight:700;text-decoration:none;padding:9px 20px;border-radius:6px;background:#4a909d;color:#fff !important;\">\ud83d\udcc4 Book of Abstracts<\/a>\n      <\/div>\n    <\/div>\n\n    <!-- CARTE 03 -->\n    <div style=\"background:#fff;border-radius:10px;padding:28px 28px 24px;border-top:4px solid #cd696b;box-shadow:0 1px 6px rgba(0,0,0,.07);display:flex;flex-direction:column;gap:12px;\">\n      <div style=\"display:flex;align-items:center;gap:10px;flex-wrap:wrap;\">\n        <span style=\"font-size:10px;font-weight:700;letter-spacing:.12em;text-transform:uppercase;background:#fce8e8;color:#a03a3c !important;padding:3px 10px;border-radius:4px;\">Scientific Highlights<\/span>\n        <span style=\"font-size:12px;color:#888 !important;\">Heidelberg, September 9\u201312, 2026<\/span>\n      <\/div>\n      <h3 style=\"font-size:16px;font-weight:700;color:#212e53 !important;margin:0;line-height:1.4;\">S\u00e9lection au congr\u00e8s ESDR 2026<\/h3>\n      <p style=\"font-size:13.5px;line-height:1.7;color:#555 !important;margin:0;\">Our team will also present a poster and deliver a Flash Talk (#9) at the upcoming European Society for Dermatological Research (ESDR) Annual Meeting, which will take place in Heidelberg from September 9 to 12, 2026. The selected abstract presents promising results from a preclinical study evaluating a novel therapeutic strategy for cutaneous neurofibromas.<\/p>\n\n      <div style=\"margin-top:8px;\">\n        <a href=\"https:\/\/esdrmeeting.org\/registration\/\" target=\"_blank\" rel=\"noopener\" style=\"display:inline-flex;align-items:center;gap:6px;font-size:13px;font-weight:700;text-decoration:none;padding:9px 20px;border-radius:6px;background:#cd696b;color:#fff !important;\">\ud83c\udf9f esdrmeeting.org<\/a>\n      <\/div>\n    <\/div>\n\n  <\/div>\n\n  <!-- LIGNE 3 : cartes 04 et 05 c\u00f4te \u00e0 c\u00f4te -->\n  <div style=\"display:grid;grid-template-columns:1fr 1fr;gap:20px;\">\n\n    <!-- CARTE 04 -->\n    <div style=\"background:#212e53;border-radius:10px;padding:28px 28px 24px;border-top:4px solid #bdd2c2;box-shadow:0 1px 6px rgba(0,0,0,.1);display:flex;flex-direction:column;gap:12px;\">\n      <div style=\"display:flex;align-items:center;gap:10px;flex-wrap:wrap;\">\n        <span style=\"font-size:10px;font-weight:700;letter-spacing:.12em;text-transform:uppercase;background:rgba(189,210,194,.2);color:#bdd2c2 !important;padding:3px 10px;border-radius:4px;\">Upcoming<\/span>\n        <span style=\"font-size:12px;color:rgba(255,255,255,.45) !important;\">Vienna, November 12\u201314, 2026<\/span>\n      <\/div>\n      <h3 style=\"font-size:16px;font-weight:700;color:#fff !important;margin:0;line-height:1.4;\">European Neurofibromatosis Congress<\/h3>\n      <p style=\"font-size:13.5px;line-height:1.7;color:rgba(255,255,255,.72) !important;margin:0;\">Join us in Vienna from November 12 to 14, 2026, for the next European Neurofibromatosis Meeting. CERENEF is proud to contribute to the organization of this major event, which will bring together clinicians, researchers, and patient organizations to share the latest advances in the field of neurofibromatoses.<\/p>\n\n      <div style=\"margin-top:8px;\">\n        <a href=\"https:\/\/eunf2026vienna.com\" target=\"_blank\" rel=\"noopener\" style=\"display:inline-flex;align-items:center;gap:6px;font-size:13px;font-weight:700;text-decoration:none;padding:9px 20px;border-radius:6px;background:#bdd2c2;color:#212e53 !important;\">\ud83c\udf0d eunf2026vienna.com<\/a>\n      <\/div>\n    <\/div>\n\n    <!-- CARTE 05 -->\n    <div style=\"background:#fff;border-radius:10px;padding:28px 28px 24px;border-top:4px solid #7aab85;box-shadow:0 1px 6px rgba(0,0,0,.07);display:flex;flex-direction:column;gap:12px;\">\n      <div style=\"display:flex;align-items:center;gap:10px;flex-wrap:wrap;\">\n        <span style=\"font-size:10px;font-weight:700;letter-spacing:.12em;text-transform:uppercase;background:#e8f2ea;color:#3d7a4e !important;padding:3px 10px;border-radius:4px;\">Continuing Medical Education (CME)<\/span>\n        <span style=\"font-size:12px;color:#888 !important;\">Paris, December 2026<\/span>\n      <\/div>\n      <h3 style=\"font-size:16px;font-weight:700;color:#212e53 !important;margin:0;line-height:1.4;\">Rendez-vous aux JDP 2026<\/h3>\n      <p style=\"font-size:13.5px;line-height:1.7;color:#555 !important;margin:0;\">Two Continuing Medical Education (CME) sessions organized by CERENEF have been selected for the scientific program of the 2026 Journ\u00e9es Dermatologiques de Paris.<\/p>\n      <div style=\"display:flex;flex-direction:column;gap:10px;\">\n        <div style=\"background:#f0f6f2;border-left:3px solid #4a909d;border-radius:0 6px 6px 0;padding:12px 16px;\">\n          <div style=\"font-size:13px;font-weight:700;color:#212e53 !important;margin-bottom:4px;\">CME19 \u2013 Neurofibromatoses: Fundamentals in Outpatient and Hospital Practice<\/div>\n          <div style=\"font-size:12px;color:#666 !important;\">\ud83d\udcc5 December 2, 2026, at 2:15 PM<\/div>\n        <\/div>\n        <div style=\"background:#f0f6f2;border-left:3px solid #4a909d;border-radius:0 6px 6px 0;padding:12px 16px;\">\n          <div style=\"font-size:13px;font-weight:700;color:#212e53 !important;margin-bottom:4px;\">CME58 \u2013 Caf\u00e9-au-lait Macules and Other Pigmented Lesions: When Should a Genodermatosis Be Suspected?<\/div>\n          <div style=\"font-size:12px;color:#666 !important;\">\ud83d\udcc5 December 3, 2026, at 4:15 PM<\/div>\n        <\/div>\n      <\/div>\n      <div style=\"margin-top:4px;\">\n        <a href=\"https:\/\/www.lesjdp.fr\/\" target=\"_blank\" rel=\"noopener\" style=\"display:inline-flex;align-items:center;gap:6px;font-size:13px;font-weight:700;text-decoration:none;padding:9px 20px;border-radius:6px;border:2px solid #4a909d;color:#4a909d !important;background:transparent;\">\ud83c\udf93 lesjdp.fr<\/a>\n      <\/div>\n    <\/div>\n\n  <\/div>\n\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Centre de r\u00e9f\u00e9rence Actualit\u00e9s Neurofibromatoses R\u00e9seau europ\u00e9en Une nouvelle dynamique europ\u00e9enne avec le COST Action INTERACT-NF (CA25150) Notre candidature au COST Action INTERACT-NF (CA25150) a \u00e9t\u00e9 retenue avec succ\u00e8s. Ce r\u00e9seau europ\u00e9en a pour objectif de renforcer la collaboration entre cliniciens, chercheurs fondamentaux et translationnels, personnes concern\u00e9es et familles, partenaires industriels et institutionnels, afin d&rsquo;acc\u00e9l\u00e9rer&hellip;&nbsp;<\/p>\n<div class=\"read-more-wrapper\"><a href=\"https:\/\/cerenef.org\/en\/actualites\/\" class=\"button button-secondary\" rel=\"bookmark\">\u279c Read more<span class=\"screen-reader-text\">News<\/span><\/a><\/div>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","neve_meta_reading_time":"","footnotes":""},"categories":[8],"tags":[],"class_list":["post-4303","post","type-post","status-publish","format-standard","hentry","category-actualites"],"_links":{"self":[{"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/posts\/4303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/comments?post=4303"}],"version-history":[{"count":16,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/posts\/4303\/revisions"}],"predecessor-version":[{"id":4325,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/posts\/4303\/revisions\/4325"}],"wp:attachment":[{"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/media?parent=4303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/categories?post=4303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/tags?post=4303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}